fosamprenavir


Also found in: Medical, Wikipedia.
Related to fosamprenavir: ritonavir
Translations

fosamprenavir

n fosamprenavir m
References in periodicals archive ?
8 sgb v as part of the approval procedure for drug fosamprenavir, j05ae07 during the period from 12.
FDA-Approved Antiretroviral Agents Nucleoside RTIs Nonnucleoside RTIs Protease inhibitors abacavir (ABC) delavirdine (DLV) atazanavir (ATV) didanosine (ddl) efavirenz (EFZ) darunavir (DRV) emtricitabine (FTC) etravirine (ETV) fosamprenavir (Fos-APV) lamivudine (3TC) nevirapine (NVP) indinavir (IDV) stavudine (d4T) lopinavir/r (LPV/r) zidovudine (ZDV) nelfinavir (NFV) ritonavir (RTV) saquinavir (SQV) tipranavir (TPV) Nucleotide RTI Integrase inhibitor Fusion inhibitor tenofovir DF (TDF) raltegravir (RAL) enfuvirtide (T-20) CCR5 antagonist maraviroc (MVC) Notes: Six fixed-dose combinations are approved by the Food and Drug Administration.
The 2008 IAS-USA guidelines (8) for initial antiretroviral therapy recommend either of two basic three-drug regimens: efavirenz plus two NRTIs, or a ritonavir-boosted protease inhibitor (lopinavir, atazanavir, fosamprenavir, darunavir or saquinavir) plus two NRTIs.
Rifampicin reduces levels of lopinavir, indinavir, saquinavir, atazanavir, fosamprenavir (PIs) and nevirapine and should not be used with any of these drugs.
HIV/AIDS drugs proposed under the Patent Pool of the UNITAIDS Compound Company Lopinavir (LPV) Abbott Ritonavir (r) Abbott Nevirapine (NVP) Boehringer-Ingelheim Atazanavir (ATV) Bristol Myers Squibb GS-9350 Gilead Elvitegravir (EVG) Gilead Tenofovir (TDF) Gilead Emtricitabine (FTC) Gilead Efavirenz (EFV) Merck Raltegravir (RAL) Merck Vicriviroc Merck (Schering-Plough) Saquinavir (SQV) Roche Etravirine (ETR) Tibotec / J&J Darunavir (DRV) Tibotec / J&J Rilpivirine Tibotec / J&J Lamivudine (3TC) Viiv (GSK) Abacavir (ABC) Viiv (GSK) Fosamprenavir (FSV) Viiv (GSK) Maraviroc Viiv (Pfizer)
34,36) There are nine FDA-approved PIs: ritonavir, amprenavir, fosamprenavir, indinavir, lopinavir (manufactured in combination with ritonavir), nelfinavir, saquinavir, atazanavir, and tipranavir.
Coadministration of esomeprazole (ESO) with fosamprenavir (fAPV) has no impact on steady-state plasma amprenavir (APV) pharmacokmetics (APV10031).
Significant interactions were observed between telaprevir and boosted-lopinavir, darunavir and fosamprenavir, such that telaprevir-based combination therapy is not currently being evaluated for people taking these HIV medicines.
Supply of Medicine: Abacavir / Lamivudine Fosamprenavir, zidovudine / Abacavir / Lamivudine" _ Expte.
Fosamprenavir is not approved for use in infants but is currently being evaluated in South African children 1-6 months old.
Another preferred PI-based regimen is ritonavir-boosted fosamprenavir plus two NRTIs.
KALETRA should not be given once-daily in combination with Sustiva(R) (efavirenz), Viramune(R) (nevirapine), Agenerase(R) (amprenavir), fosamprenavir, Viracept(R) (nelfinavir), phenobarbital, Dilantin(R) (phenytoin) or Tegretol(R) (carbamazepine).